MyAverix Finance
NS · Pharmaceuticals
Lyka Labs Ltd (LYKALABS)
Pharmaceuticals & Biotechnology
Lyka Labs Ltd (LYKALABS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $2.41B, P/E ratio is -7.35, net margin is -7.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LYKALABS
Lyka Labs Ltd (LYKALABS) — FAQ
What is Lyka Labs Ltd's market cap?
Lyka Labs Ltd (LYKALABS) has a reported market cap of $2.41B (data as of 2026-07-11).
What is LYKALABS's P/E ratio?
The price-to-earnings (P/E) ratio for Lyka Labs Ltd (LYKALABS) is -7.35 (data as of 2026-07-11).
Does Lyka Labs Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Lyka Labs Ltd (LYKALABS). Check the MyAverix Finance app for the latest dividend data.
What sector is Lyka Labs Ltd in?
Lyka Labs Ltd (LYKALABS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is LYKALABS listed on?
LYKALABS is listed on NS.
What is Lyka Labs Ltd's net margin?
Lyka Labs Ltd (LYKALABS) reports a net margin of -7.3% (data as of 2026-07-11).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.